LTRN icon

Lantern Pharma
LTRN

Overview Fund Activity

27 hedge funds and large institutions have $3.93M invested in Lantern Pharma in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
27
Holders Change
+2
Holders Change %
+8%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
5
Reduced
8
Closed
1
Calls
$8K
Puts
$23K
Net Calls
-$15K
Net Calls Change
-$15K

Top Buyers

1
PFA
Pathway Financial Advisors
Vermont
$112K
2
MWM
Meridian Wealth Management
Kentucky
$56.8K
3
Citadel Advisors
Citadel Advisors
Florida
$104K
4
Geode Capital Management
Geode Capital Management
Massachusetts
$324K
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
$31

Top Sellers

1
WWM
Wolff Wiese Magana
California
$7.5K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
$0
3
Renaissance Technologies
Renaissance Technologies
New York
$130K
4
NA
NewEdge Advisors
Louisiana
$580K
5
Commonwealth Equity Services
Commonwealth Equity Services
Massachusetts
$52K
Name Holding Trade Value Shares
Change 		Shares
Change %
Qube Research & Technologies (QRT)
26
Qube Research & Technologies (QRT)
United Kingdom
$7 +$7 +2 New
Susquehanna International Group
27
Susquehanna International Group
Pennsylvania
– -$59.7K -10,581 Closed
1
2